Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Xenon Pharmaceuticals Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- −6 vs. Q1 2024
- Shares held
- 74.2M
- +766.8K (+1.0%) vs. Q1 2024
- Total value
- $2.89B
- −$268.1M (−8.5%) vs. Q1 2024
- New holders
- 21
- 78 more added
- Sold out
- 27
- 71 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XENE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 315 | $6.10B |
| Q1 2026 | 290 | $5.80B |
| Q4 2025 | 245 | $3.78B |
| Q3 2025 | 219 | $3.39B |
| Q2 2025 | 206 | $2.60B |
| Q1 2025 | 206 | $2.58B |
| Q4 2024 | 209 | $2.99B |
| Q3 2024 | 203 | $2.95B |
| Q2 2024 | 213 | $2.89B |
| Q1 2024 | 220 | $3.16B |
| Q4 2023 | 204 | $3.32B |
| Q3 2023 | 181 | $2.10B |
| Q2 2023 | 175 | $2.36B |
| Q1 2023 | 163 | $2.19B |
| Q4 2022 | 159 | $2.38B |
| Q3 2022 | 154 | $2.09B |
| Q2 2022 | 151 | $1.73B |
| Q1 2022 | 132 | $1.50B |
| Q4 2021 | 130 | $1.49B |
| Q3 2021 | 118 | $521.7M |
| Q2 2021 | 103 | $620.0M |
| Q1 2021 | 91 | $590.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Xenon Pharmaceuticals Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alliancebernstein L.P. | 1,483,166 | $57.8M | 0.02% | +14,720+1.0% | Added |
| Adage Capital Partners GP, L.L.C. | 1,839,555 | $71.7M | 0.13% | +167,638+10.0% | Added |
| Paradigm Biocapital Advisors LP | 2,043,280 | $79.7M | 3.05% | −441,594−17.8% | Reduced |
| BlackRock Inc. | 2,095,894 | $81.7M | 0.00% | −26,034−1.2% | Reduced |
| Capital International Investors | 2,475,859 | $96.5M | 0.02% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 2,536,058 | $98.9M | 0.58% | −76,050−2.9% | Reduced |
| Braidwell LP | 2,560,573 | $99.8M | 3.13% | +1,252,562+95.8% | Added |
| Capital World Investors | 2,681,537 | $104.6M | 0.02% | 00.0% | Unchanged |
| Commodore Capital LP | 2,754,266 | $107.4M | 7.33% | +586,473+27.1% | Added |
| Wellington Management Group LLP | 3,828,221 | $149.3M | 0.03% | −93,837−2.4% | Reduced |
| Driehaus Capital Management LLC | 4,419,472 | $172.3M | 1.67% | +97,732+2.3% | Added |
| Avoro Capital Advisors LLC | 5,666,666 | $220.9M | 2.94% | 00.0% | Unchanged |
| FMR LLC | 6,768,173 | $263.9M | 0.02% | +166,343+2.5% | Added |
| Great Point Partners LLC | 0 | $0 | 0.00% | −456,148−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −167,926−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −66,090−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −42,473−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −16,085−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −15,092−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −14,451−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −11,402−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −9,700−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −9,649−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −9,603−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −7,987−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −6,900−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −6,661−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −5,662−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −5,286−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,105−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −4,972−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −4,864−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −909−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −302−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| JFS Wealth Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| SJS Investment Consulting Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| DiNuzzo Private Wealth, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| 17 Capital Partners, LLC | 0 | $0 | 0.00% | −2,840−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |